Skip to content
S6763Senate2021-2022 SessionSame asA7847

Cap Pharmacy Fees for Costly Drugs

Official title

“Determines the amount paid to a pharmacy for certain high cost drugs”

Sponsor Diane J. SavinoSD-23+2 co-sponsorsAffects Health
Status
In Senate Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

The bill limits pharmacy payments for high-cost drugs in Medicaid to 2.5% above acquisition cost, plus administrative and dispensing fees.

Why it matters

  1. Targets "high cost" drugs. by specifically capping Medicaid pharmacy reimbursements only for drugs with an acquisition cost over $670, potentially impacting access and pricing for some of the most expensive medications.

  2. Limits pharmacy profit margins. to a strict 2.5% above what the pharmacy pays to acquire the drug, plus a set administrative and dispensing fee, which could influence which pharmacies are willing to stock or dispense these high-cost drugs.

  3. Shifts financial pressure. from Medicaid and taxpayers onto pharmacies, potentially leading to fewer participating pharmacies for certain expensive drugs, and may impact patient access or waiting times for these medications.

  4. Creates a state-level precedent. for how public insurance programs handle high-cost prescription drugs, potentially influencing future policy debates around drug pricing, pharmacy reimbursement, and healthcare cost containment.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Cap Pharmacy Fees for Costly Drugs

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Diane J. Savino

Senator · Senate District 23

Chair, Internet And Technology

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A7847Assembly

Limit Pharmacy High-Cost Drug Payments

In Assembly Committee · Health · Sponsor Karines Reyes

Impact 6 · Moderate0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

6763

2021-2022 Regular Sessions

IN SENATE

May 14, 2021

Introduced by Sen. SAVINO -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the social services law, in relation to determining the amount paid to a pharmacy for certain high cost drugs

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Paragraph (b) of subdivision 9 of section 367-a of the social services law is amended by adding a new subparagraph (iv) to read as follows:

(iv) notwithstanding subparagraphs (i) and (ii) of this paragraph and paragraph (e) of this subdivision, if the drug dispensed is a high cost drug and has a national average drug acquisition cost set by the federal center for medicare and medicaid services in excess of six hundred seventy dollars, the actual amount paid to the pharmacy, plus the reasonable administrative costs as determined by the commissioner of health, shall be no more than two and one-half percent of the total cost of such drug, together with any dispensing fee authorized under paragraph (d) of this subdivision.

§ 2. This act shall take effect immediately; provided, however, that the amendments to subdivision 9 of section 367-a of the social services law made by section one of this act shall not affect the expiration of such subdivision and shall be deemed to expire therewith.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD11420-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the social services law, in relation to determining the amount paid to a pharmacy for certain high cost drugs

Purpose

Provides for a reimbursement for high cost drugs using the federally recognized threshold, medications that cost over $670 must be reimbursed at a rate of NADAC price + 2.5% + the $10.08 dispensing fee

Summary of provisions

Paragraph (b) of subdivision 9 of section 367-a of the social services law is amended by adding a new paragraph (iv) - set high cost drug as having a national average drug acquisition cost set by the federal government for Medicaid/Medicare in excess of $675 the actual amount paid to a pharmacy shall be no more than 2 1/2 % of the total cost, plus reasonable administrative costs and dispending fees.

Existing law

The State Department of Health pays the pharmacist according to a formu- la. Under fee for service, the formula has been streamlined into a "1-size-fits-all approach": NADAC + $10.08. Then, once that amount is calculated, the State "claws back" 1.5% of the total reimbursement.

Justification

Pharmacy drug pricing has become both complicated and convoluted. Essentially, a pharmacist purchases a drug from a wholesaler, holds the drug in inventory until a prescription is presented for that drug. When the patient receives the drug, s/he is responsible for the applicable co-pay (However, if a Medicaid patient claims an inability to pay, the pharmacist must waive it and absorb the loss for prescription to be dispensed). The pharmacist is out the money paid for the drug, and now must purchase the drug to replace it in stock. The pharmacist must then wait for the Medicaid program to pay for the drug that the patient received. The pharmacist is not paid according to the actual price paid for the drug. Rather, the State Department of Health pays the pharmacist according to a formula. Under fee for service, the formula has been streamlined into a "1-size-fits-all approach": NADAC + $10.08. Then, once that amount is calculated, the State "claws back" 1.5% of the total reimbursement.

It is unrealistic to ask independent pharmacies, which are also small businesses, to purchase these drugs from wholesalers, stock and provide them to patients, only to lose money. In order to ensure patient access to these needed medications, New Yorkers deserve a tiered pharmacy reimbursement system. Using the federally recognized threshold, medica- tions that cost over $670 must be reimbursed at a rate of NADAC price + 2.5% + the $10.08 dispensing fee. Most importantly, the patients who need these medications will continue to have access.

Legislative history

2021 Session - new bill

Fiscal implications

To be determined

Effective date

This act shall take effect immediately; provided, however, that the amendments to subdivision 9 of section 367-a of the social services law made by section one of this act shall not affect the expiration of such subdivision and shall be deemed to expire herewith.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.